You are here

  • Home
  • Archive
  • Volume 74, Issue 10
  • PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus

Article info

Article menu
Clinical and epidemiological research
Concise report
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus

Authors

  • John Bowes Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Sabine Loehr Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Ashley Budu-Aggrey Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Steffen Uebe Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Ian N Bruce Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK The Kellgren Centre for Rheumatology, Central Manchester Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Marie Feletar Monash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Helena Marzo-Ortega NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • Philip Helliwell NIHR-Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • Anthony W Ryan Department of Clinical Medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • David Kane Adelaide and Meath Hospital and Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Eleanor Korendowych Royal National Hospital for Rheumatic Diseases and Department Pharmacy and Pharmacology, University of Bath, Bath, UK PubMed articlesGoogle scholar articles
  • Gerd-Marie Alenius Department of Public Health and Clinical Medicine, Rheumatology, University Hospital, Umeå, Sweden PubMed articlesGoogle scholar articles
  • Emiliano Giardina Department of Biopathology, Centre of Excellence for Genomic Risk Assessment in Multifactorial and Complex Diseases, School of Medicine, University of Rome ‘Tor Vergata’ and Fondazione PTV ‘Policlinico Tor Vergata’, Rome, Italy PubMed articlesGoogle scholar articles
  • Jonathan Packham Rheumatology Department, Haywood Hospital, Health Services Research Unit, Institute of Science and Technology in Medicine, Keele University PubMed articlesGoogle scholar articles
  • Ross McManus Department of Clinical Medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Oliver FitzGerald Department of Rheumatology, St. Vincent's University Hospital, UCD School of Medicine and Medical Sciences and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Matthew A Brown The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Frank Behrens Division of Rheumatology and Fraunhofer IME-Project-Group Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Harald Burkhardt Division of Rheumatology and Fraunhofer IME-Project-Group Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany PubMed articlesGoogle scholar articles
  • Neil McHugh Royal National Hospital for Rheumatic Diseases and Department Pharmacy and Pharmacology, University of Bath, Bath, UK PubMed articlesGoogle scholar articles
  • Ulrike Huffmeier Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Pauline Ho Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK The Kellgren Centre for Rheumatology, Central Manchester Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester, UK PubMed articlesGoogle scholar articles
  • Andre Reis Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Anne Barton Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK The Kellgren Centre for Rheumatology, Central Manchester Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correpondence to Professor Anne Barton, Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Manchester M13 9PT, UK; anne.barton{at}manchester.ac.uk
View Full Text

Citation

Bowes J, Loehr S, Budu-Aggrey A, et al
PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus
Annals of the Rheumatic Diseases 2015;74:1882-1885.

Publication history

  • Received December 19, 2014
  • Revised March 3, 2015
  • Accepted April 5, 2015
  • First published April 28, 2015.
Online issue publication 
October 25, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/